Interview

When Bayer bought US seed-maker Monsanto for $63 billion in 2018, it inherited billions of dollars worth of lawsuits from farmers who claimed its weedkiller, Roundup had caused their cancer. Today Bayer’s entire market value is less than half of what it spent to buy Monsanto. DW Business sat down with Bayer CEO Bill Anderson to ask him how he plans to turn his company’s fortunes around.